2023 US Interchange Program
Program is subject to change.
All times in US Eastern Time
Click each session to expand to see the presentations, speakers, and summaries.
Session 1: Opening Plenary
For the last 20 years, we have navigated from binding folders in boxes, to study data standardization, and electronic submissions. The new landscape is bringing new types of data and technology is continuously evolving around us. In some areas, we have transformed process and capabilities yet in others, we remain stuck in rigid frameworks that have gone unquestioned for decades. The aim of this presentation is to leave you pondering: Is it possible to transform drug development and regulatory assessments?
Session 2: Second Opening Plenary
Session 3A: Digitization and AI
Session 3B: Business Optimization
Session 3C: ARS Hands-On Workshop
This workshop will train attendees on the Analysis Results Standards (ARS) model and provide in-depth exploration of key concepts, available examples, and documentation. Through real-world use cases and implementation examples from the CDISC ARS Hackathon, we'll demonstrate the practical application of ARS and discuss the next steps for adopting it in your organization. We will provide practical insights and hands-on exercises to equip you with the knowledge and skills to leverage the CDISC ARS model effectively.
Note: Attendees are encouraged to bring their laptops to actively participate in the training exercises and maximize their learning experience.
Session 4A: Real World Data + Implementation
Session 4B: CDISC Foundational, Part I
Non-standard variables (NSVs) are used to represent concepts in SDTM datasets that cannot be represented using standard variables found in the SDTM model. Published NSVs can be found in CDISC IGs, TAUGs, and QRS supplements. However, the non-standard nature of these variables mean that different labels for the same concept and the same label for different concepts may appear across published documents. Therefore some kind of formalism is needed to support the efficient generation and re-use of NSVs. In order to address this challenge, a standards team was formed to identify the extent of the issue, perform an analysis, and deliver a solution. We will describe the NSV Registry, an accessible repository that serves as a reference for searching, requesting, and curating non-standard variables, in order to drive consistency in implementing CDISC Standards.
Session 4C: COSA Session - 360 & End-to-End
Session 5A: CDISC Strategic Updates- Biomedical Concepts & CORE
Session 5B: Updates Towards Regulatory
- Helena Sviglin, FDA-CDER
- Korey Hendricks, BMS
- Scout, National LGBT Cancer Network
- Garo Kiledjian, SGM Alliance
Session 5C: Workshop - Evaluating Safety, Quality and Traceability of Regulatory Submission Data
- Import CDISC data into JMP Clinical software
- Basic JMP Clinical function
- Create safety and data quality reports automatically according to clinical trial data
- Follow FDA NDA safety template to understand the drug safety analysis with figures and tables in NDAs and CRs from JMP Clinical reports such as Demographics, Interventions, Events, Findings, Patient Profiles and Narratives
- Explore adverse event reporting strategies such as comparing FMQ (FDA Medical Queries) and SMQ (Standardized Medical Queries)
Session 6A: Digital Data Flow
Session 6B: CDISC Foundational, Part II
Session 6C: CORE Workshop
CDISC Open Rules Engine (CORE) experts will provide a hands-on Workshop where you will learn the ins and outs of CORE.
We will show you how to create existing CDISC conformance, regulatory, and sponsor-specific rules, along with data quality checks using the CORE Rules Editor.
Attendees are encouraged to bring their laptops and ensure they are set up with a cdiscID .
Session 7: Third Plenary - Regulatory Presentations
- Jesse Anderson, FDA-CDER
- Helena Sviglin, FDA-CDER
- Yuki Ando, PMDA
- Chrissie Cai, FDA-CTP
- Lisa Lin, FDA-CBER